Mariano Provencio-Pulla

34PUBLICATIONS
277CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 25, 2026
ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2.

|Sep 11, 2026
Neo-DIANA: descriptive results of a prematurely terminated phase II trial of neoadjuvant atezolizumab, chemotherapy and bevacizumab in resectable EGFR-mutated NSCLC.

|Aug 12, 2026
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.

|May 21, 2026
Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.

|Apr 15, 2026
Mediastinal staging and restaging techniques in locally advanced non-small cell lung cancer in the era of neoadjuvant and perioperative chemoimmunotherapy-a narrative review.

María Izquierdo-Chamarro, Aylen Vanessa Ospina-Serrano, Mariano Provencio-Pulla

|Mar 10, 2026
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

Pageof 6

Frequent Collaborators

9 joint publications

Alberto Cruz-Bermúdez

8 joint publications

Ernest Nadal

8 joint publications

Virginia Calvo

8 joint publications

Javier De Castro Carpeño